Percentage of all adult (>=18 years old) hemodialysis or peritoneal dialysis patients prescribed an ESA at any time during the study period or who have a Hb <11.0 g/dL in at least one month of the study period for whom serum ferritin concentration AND either percent transferrin saturation or reticulocyte Hb content (CHr) are measured at least once in a three-month period for in-center hemodialysis patients, peritoneal dialysis patients, and home hemodialysis patients.
- Measure TypeElectronic Clinical Quality Measure (eCQM)Level Of AnalysisCare SettingNumerator
Number of dialysis patients in the denominator for whom serum ferritin concentration AND either percent transferrin saturation or reticulocyte Hb content (CHr) are measured at least once in a three-month period for in-center hemodialysis patients, peritoneal dialysis patients, and home hemodialysis patients.
DenominatorAll adult (>=18 years old) hemodialysis or peritoneal dialysis patients prescribed an ESA at any time during the study period or who have a Hb <11.0 g/dL in at least one month of the study period. The study period consists of 3 consecutive months for in-center hemodialysis patients, peritoneal dialysis patients and home hemodialysis. The hemoglobin value reported for the end of each study month (end-of-month Hb) is used for this calculation.
ExclusionsAcute HD, transient dialysis patients (seen at the specific center for less than 30 days), and kidney transplant patients are excluded from the calculation this CPM.
Testing Data Sources
- Measure StructureClinical Condition Topic AreaTarget Population
- Risk Adjustment
- Current or planned use(s)
- Most Recent Endorsement ActivityMeasure Retired and Endorsement Removed Renal Consensus Standards Endorsement Maintenance 2011Initial EndorsementEndorsement StatusLast UpdatedRemoval Date
- Steward Organization Email